Some of the questions clearly show that people haven't taken the time to read the documents last week
I did like the question about 'if the trial is recommended to be stopped by the DSMB will there be discussions with the FDA with MSB before officially stopping it' .... and the answer was a big yes, so at least MSB will be involved in this process to ensure their is enough robust data to ensure an approval for COVID-19 ARDS .... a very positive answer and a question many of us have been discussing on here .... gives me a great deal of confidence and I am assuming Novartis would be involved in those discussions now also
AGM Discussion, page-20
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.055(3.77%) |
Mkt cap ! $1.729B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.54 | $1.45 | $6.072M | 4.049M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5951 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 133644 | 5 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |